{"retracted":false,"update":{"timestamp":1486425600000,"doi":"10.1007/s12185-017-2196-2","type":"correction"},"doi":"10.1007/s12185-016-2130-z","journal":"International Journal of Hematology","publisher":"Springer Nature","title":"Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis"}
